From: Prevalence and characteristics of COVID-19 vaccine breakthrough infection in Upper Egypt
Post-vaccine COVID-19 | P value* | ||
---|---|---|---|
Group A (n= 299) | Group B (n= 70) | ||
Age (years) | 27.66 ± 12.29 | 37.17 ± 17.97 | < 0.001 |
Sex | |||
Male | 164 (54.8%) | 39 (55.7%) | 0.50 |
Female | 135 (45.2%) | 31 (44.3%) | |
Residence | |||
Rural | 141 (47.2%) | 33 (47.1%) | 0.55 |
Urban | 158 (52.8%) | 37 (52.9%) | |
Marital status | |||
Married | 84 (28.1%) | 32 (47.1%) | 0.01 |
Single | 215 (71.9%) | 37 (52.9%) | |
Occupation | |||
Employee | 99 (33.1%) | 47 (67.1%) | < 0.001 |
Worker | 8 (2.7%) | 5 (7.1%) | |
None | 28 (9.4%) | 5 (7.1%) | |
Student | 164 (54.8%) | 13 (18.6%) |